Sanofi Consumer Healthcare India Q1 Profit Up to ₹678 Crore

April 28, 2026 1 min read Firehose Gupta

Sanofi Consumer Healthcare India Limited — Quarter ended March 31, 2026

Particulars	Quarter ended 31.03.2026 (Unaudited)	Quarter ended 31.12.2025 (Unaudited) Refer Note 9	Quarter ended 31.03.2025 (Unaudited)	Year ended 31.12.2025 (Audited)
1. Revenue from Operations (Refer note 8)	2,292	2,510	1,726	8,784
2. Other Income	56	46	52	184
3. Total Income (1+2)	2,348	2,556	1,778	8,968
4. Expenses
(a) Cost of Materials Consumed	402	499	189	1,607
(b) Purchases of stock in trade	181	61	335	702
(c) Changes in Inventories of work-in-progress, stock-in-trade and finished goods	(21)	123	(136)	(8)
(d) Employee benefits expense (Refer note 4)	331	355	296	1,288
(e) Finance costs	5	5	4	20
(f) Depreciation and amortisation expense	32	34	20	117
(g) Other expenses	511	574	402	2,105
Total Expenses	1,441	1,651	1,110	5,831
5. Profit before exceptional items and tax (3-4)	907	905	668	3,137
6. Exceptional items (Refer note 5)	–	–	–	66
7. Profit before tax (5+6)	907	905	668	3,203
8. Tax expense
Current Tax	241	241	170	820
Deferred Tax	(12)	(1)	(2)	(18)
9. Profit for the period /year (7-8)	678	665	500	2,401
10. Other comprehensive income (OCI)
Items that will not be reclassified to the statement of profit and loss
– Remeasurements of post-employment benefit obligations	–	(19)	–	(19)
– Income Tax impact relating to these items	–	5	–	5
11. Total comprehensive income for the period/year (9+10)	678	651	500	2,387
12. Paid-up equity share capital (Face Value of ₹ 10 per share)	230	230	230	230
13. Other equity	–	–	–	3,610
14. Basic and diluted earnings per share (not annualised) (in ₹)	29.44	28.87	21.69	104.27

Particulars	Quarter ended 31.03.2026 (Unaudited)	Quarter ended 31.12.2025 (Unaudited)	Quarter ended 31.03.2025 (Unaudited)	Year ended 31.12.2025 (Audited)
Sales of Product	2,063	2,330	1,586	8,045

More from the same coverage lane.